WHOLE GENOME DNA METHYLATION AND GENOTYPING FOR SLE PATIENTS, THIRD PHASE
Award details are derived from public USAspending.gov records linked to this contractor. Not a bid recommendation.
Award details
- Award ID
- 75N92024P00266
- Awarding agency
- Department of Health and Human Services
- Sub-agency / office
- National Institutes of Health
- Award amount
- $282,791
- Period of performance
- Sep 8, 2024 – Apr 30, 2026
- Place of performance
- BERKELEY, CA, 947101749, USA
- Competition
- NOT COMPETED UNDER SAP · Set-aside: NO SET ASIDE USED. · 1 offers
- Pricing
- FIRM FIXED PRICE
- Financial breakdown
- Current value $282,791 · Obligated $282,791 · Potential value $282,791 · Latest action obligation $0 · Outlays $282,791
Public award description
WHOLE GENOME DNA METHYLATION AND GENOTYPING FOR SLE PATIENTS, THIRD PHASE
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Contractor: REGENTS OF THE UNIVERSITY OF CALIFORNIA, THE
- Agency: Department of Health and Human Services
- Federal market intelligence software